Correction: Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs.
Lopez J, Mommert M, Mouton W, Pizzorno A, Brengel-Pesce K, Mezidi M, Villard M, Lina B, Richard JC, Fassier JB, Cheynet V, Padey B, Duliere V, Julien T, Paul S, Bastard P, Belot A, Bal A, Casanova JL, Rosa-Calatrava M, Morfin F, Walzer T, Trouillet-Assant S.
Lopez J, et al.
J Exp Med. 2021 Oct 4;218(10):jem.2021121108132021c. doi: 10.1084/jem.2021121108132021c. Epub 2021 Aug 20.
J Exp Med. 2021.
PMID: 34415984
Free PMC article.
No abstract available.